Item 1A. RISK FACTORS
2K characters. Original on sec.gov · Markdown
Item 1A. RISK FACTORS
There have been no material changes to the risk factors included in our 2021 Form 10-K under the heading “Risk Factors Relating to Our Business” and “Risk Factors Relating to Regulation”.
ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
The table below sets forth information regarding purchases of our common stock primarily related to our share repurchase program that were made by us or on our behalf during the three months ended March 31, 2022.
| ($ in millions, except per share data) | Total Number of Shares Purchased**(a)** | Average Price Paid Per Share**(b)** | Total Number of Shares Purchased as Part of Publicly Announced Programs**(c)** | Maximum Dollar Value of Shares That May Yet Be Purchased Under the Programs**(b)** | |||||||||||||||||||
| January 1 - 31, 2022 | 5,661,679 | $ | 46.32 | 5,223,267 | $ | 976.0 | |||||||||||||||||
| February 1 - 28, 2022 | 16,469,708 | 43.21 | 16,469,700 | 264.3 | |||||||||||||||||||
| March 1 - 31, 2022 | 775,649 | 39.75 | 333,744 | 250.9 | |||||||||||||||||||
| Total | 22,907,036 | $ | 43.86 | 22,026,711 | $ | 250.9 |
(a)Includes 438,412 shares, 8 shares and 441,905 shares withheld in January, February and March, respectively, to offset tax withholding obligations that occur upon the delivery of outstanding shares underlying performance stock awards, restricted stock awards or upon the exercise of stock options.
(b)Amounts exclude commission costs.
(c)In May 2021 the Board of Directors approved a share repurchase program of up to $2.9 billion. In December 2021, the Board of Directors authorized an increase to the May 2021 Share Repurchase Program of $1.0 billion through the period ending June 30, 2022. In addition, in April 2022, we announced that our Board approved an incremental share repurchase authorization of $2.8 billion through June 2023.
ITEM 3. DEFAULTS UPON SENIOR SECURITIES
None.
ITEM 4. MINE SAFETY DISCLOSURES
Not applicable.
Previous: Item 4. CONTROLS AND PROCEDURES · Next: Item 5. OTHER INFORMATION